Price $12.60 |
Market Cap
86.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
7.9
|
P/B
1.04
|
P/S
0.47
|
Dividend %
-
|
|
P/CF
48.9
|
P/FCF
5.3
|
Op. Cash Flow
20.8K
|
FCF
2.4
|
|
Op. Margin
7.60%
|
Net Margin
6.00%
|
ROE
14.40%
|
ROI
15.40%
|
|
ROA
8.70%
|
EPS Growth
773.40%
|
Current Ratio
3.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $7.01 | - | - | 284.5M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.54 | - | - | 110.9M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.29 | - | - | 15.9M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $2.69 | - | - | 105.2M | Strong Buy |
| ConforMIS Inc (CFMS) | $1.20 | - | - | 247.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
